5P9I | Transferase | date | Sep 20, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Btk1 Soaked With Ibrutinib-Rev | ||||||||||||||
authors | A.S.Gardberg | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Tyrosine-Protein Kinase Btk Chain: A Fragment: Kinase Domain Synonym: Agammaglobulinemia Tyrosine Kinase,Atk,B-Cell Prog Kinase,Bpk,Bruton Tyrosine Kinase; Ec: 2.7.10.2 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Btk, Agmx1, Atk, Bpk Expression_system: Trichoplusia Ni Expression_system_taxid: 7111 Expression_system_strain: Hi5 | ||||||||||||||
symmetry | Space Group: P 21 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.11 Å | ||||||||||||
ligand | 1E8, DMS | enzyme | Transferase E.C.2.7.10.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling., Bender AT, Gardberg A, Pereira A, Johnson T, Wu Y, Grenningloh R, Head J, Morandi F, Haselmayer P, Liu-Bujalski L, Mol Pharmacol. 2017 Mar;91(3):208-219. doi: 10.1124/mol.116.107037. Epub 2017 Jan, 6. PMID:28062735 |
Data retrieval |
View 5P9I in 3D |
Visual 3D analysis of 5P9I |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5P9I |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |